VCII | ViviCells International, Inc. Annual & Quarterly

Annual Cash Flows

(In USD)

Breakdown	1999
Operating Cash Flow	-1.2 Million
Net Income	-14.43 Thousand
Depreciation & Amortization	-34.8 Thousand
Deferred income taxes	-
Stock-based compensation	-
Change in working capital	-1.59 Million
Other non-cash items	365.85 Thousand
Investing Cash Flow	-49.02 Thousand
Investments in PPE	-49.02 Thousand
Acquisitions	-
Investment purchases	-
Sales/Maturities of investments	-
Other Investing Activities	-
Financing Cash Flow	1.27 Million
Debt repayment	-1.23 Million
Dividends payments	-
Common Stock Repurchased	-
Common Stock Issuance	-
Other Financing Activities	36.98 Thousand
Accounts receivables	-1.16 Million
Accounts payables	-87.69 Thousand
Inventory	-531.99 Thousand
Other working capital	187.45 Thousand
Cash at beginning of period	-
Cash at end of period	17.51 Thousand
Capital Expenditure	-49.02 Thousand
Effect of forex changes on cash	-
Net cash flow / Change in cash	17.51 Thousand
Free Cash Flow	-1.25 Million

Breakdown	1999 FY
Operating Cash Flow	-
Net Income	-14.43 Thousand
Depreciation & Amortization	-34.8 Thousand
Deferred income taxes	-
Stock-based compensation	-
Change in working capital	-1.59 Million
Other non-cash items	365.85 Thousand
Investing Cash Flow	-49.02 Thousand
Investments in PPE	-49.02 Thousand
Acquisitions	-
Investment purchases	-
Sales/Maturities of investments	-
Other Investing Activities	-
Financing Cash Flow	1.27 Million
Debt repayment	-1.23 Million
Dividends payments	-
Common Stock Repurchased	-
Common Stock Issuance	-
Other Financing Activities	36.98 Thousand
Accounts receivables	-1.16 Million
Accounts payables	-87.69 Thousand
Inventory	-531.99 Thousand
Other working capital	187.45 Thousand
Cash at beginning of period	-
Cash at end of period	17.51 Thousand
Capital Expenditure	-49.02 Thousand
Effect of forex changes on cash	-
Net cash flow / Change in cash	17.51 Thousand
Free Cash Flow	-1.25 Million